Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03314454Phase 4Terminated
Phase 4, open-label trial (4 arms), sponsored by University of Florida. Primary endpoints: Alcohol Topography: Sip Frequency at 60 days, Alcohol Topography: Sip Interval at 60 days and 2 more. Started Oct 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03314454.